tiprankstipranks
Trending News
More News >
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Income Statement

Compare
83 Followers

Bone Biologics Income Statement

Last quarter (Q1 2025), Bone Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Bone Biologics's net income was $-1.02M. See Bone Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.22M$ 9.43M$ 3.67M$ 1.10M$ 825.01K
Depreciation and Amortization
$ 4.22M$ 9.43M$ 3.67M$ 1.10M$ 50.00
EBITDA
$ -4.11M$ 479.57K$ -4.40M$ -1.10M$ -825.00K
Operating Income
$ -4.22M$ -9.43M$ -3.67M$ -1.10M$ -825.00K
Other Income/Expenses
$ -3.11M$ 479.57K$ 2.18M$ -508.00K$ -998.00K
Pretax Income
$ -7.33M$ -8.95M$ -1.49M$ -1.61M$ -1.82M
Net Income
$ -4.11M$ -8.95M$ -1.49M$ -1.61M$ -1.82M
Per Share Metrics
Basic EPS
$ -4.83$ -34.01$ -31.15$ -37.35$ -35.68
Diluted EPS
$ -4.83$ -34.01$ -31.20$ -84.00$ -151.20
Weighted Average Shares Outstanding
1.52M 263.14K 47.60K 43.00K 51.00K
Weighted Average Shares Outstanding (Diluted)
1.52M 263.14K 47.66K 43.13K 51.14K
Currency in USD

Bone Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis